Administration of anti-CD40 in PDAC-bearing mice did not produce a significant change in the number of TAMs within the tumor, but a transitory change in macrophage activation (i.e., CD86 and MHC class II expression) was seen within 24-48 h of treatment[138]. This evidence concerns the gene CD86 and neoplasm.